Perspective Therapeutics, Inc.

CATX·NYSE American·Healthcare
Compare
2.5200−0.1400 (−5.26%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD
After hours2.5200+0.0100 (+0.40%)Oct 12, 4:01 PM EDT

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close2.6600
Open2.6100
Day range2.50502.6700
52-week range1.96006.1600
Off day high−5.62%
Off 52-week high−59.09%
Volume640.39K
Avg. volume (3M)1.59M
Market cap287.66M
EPS (TTM)-1.40
Forward P/E-2.46
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)1.85
Shares outstanding114.15M
Short interest17.34% of float
Earnings dateAug 10, 2026 (est.)
Analyst target12.2857
Profit margin0.00%

Against its peers

Compare in full ›
CATX MNPR MGNX CRDF AVBP ALXO
Market cap 287.66M 517.17M 236.96M 80.91M 811.61M 174.23M
P/E (TTM) — — — — — —
Forward P/E -2.5 -40.2 -2.5 -1.9 -4.2 -2.3
Price/book 0.9 4.0 5.5 2.7 2.2 1.3
Dividend yield — — — — — —
1-year change −47.93% −22.63% +128.05% −52.21% −17.70% −25.88%
Today −5.26% −2.42% −0.53% −3.70% −1.61% +0.80%

The closest companies by business and industry (Medical Devices). Prices may be delayed up to 15 min.

Latest news

All CATX news ›
markets.businessinsider.com·Negative

Wedbush Reaffirms Their Buy Rating on Perspective Therapeutics (CATX)

In a report released today, from Wedbush maintained a Buy rating on Perspective Therapeutics, with a price target of $11.00. In a report released on September 18, William Blair also initiated coverage with a Buy rating on the stock with a…

markets.businessinsider.com·Positive

Perspective Therapeutics initiated with an Outperform at William Blair

William Blair initiated coverage of Perspective Therapeutics (CATX) with an Outperform rating. Perspective is well positioned to leverage lead-2... Perspective Therapeutics initiated with an Outperform at William Blair William Blair…

Stock Titan·

Journey Medical: Wasatch reports 11% passive stake

An investment adviser reports passive ownership of 2.45M shares in Journey Medical (DERM). Stock Titan - [SCHEDULE 13G/A] Journey Medical Corp Amended Passive Investment Disclosure Journey Medical: Wasatch reports 11% passive stake Wasatch…

From articles in the 4Search news index.

In the news

15mentions in 30 days
13with it in the headline
Positivesentiment

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 15 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.